e-learning
resources
ERJ
2001
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms
Barcelo A., Elorza M.A., Barbe F., Santos C., Mayoralas L.R., Agusti A.G.N.
Source:
Eur Respir J 2001; 17: 728-732
Journal Issue:
April
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Barcelo A., Elorza M.A., Barbe F., Santos C., Mayoralas L.R., Agusti A.G.N.. Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur Respir J 2001; 17: 728-732
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Static lung volumes and spirometry measurements
Panel discussion on acute decompensated pulmonary hypertension
Related content which might interest you:
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms
Source: Eur Respir J 2001; 18: 1077
Year: 2001
Role of angiotensin receptors in the preclinical cardiovascular risk in obstructive sleep apnea patients
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea
Year: 2006
The association of angiotensin-converting enzyme gene insertion/deletion polymorphisms with OSA: a meta-analysis
Source: Eur Respir J 2012; 40: 394-399
Year: 2012
Is obstructive sleep apnoea a risk factor for cardiovascular disease?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005
Metabolic disturbances in patients with obstructive sleep apnoea syndrome
Source: Eur Respir Rev 2007; 16: 196-202
Year: 2007
Sleep apnoea, hypertension and vascular disease: where are we now?
Source: Eur Respir Rev 2007; 16: 169-182
Year: 2007
Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012
The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome
Source: Eur Respir J 2009; 33: 646-655
Year: 2009
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002
Cystatin C and albuminuria as markers of kidney and cardiovascular diseases in obstructive sleep apnoea syndrome (OSAS)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Insulin resistance and insulin sensitivity in patients with sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases?
Source: Sleep and Breathing Conference 2017
Year: 2017
5-lipoxygenase pathway: one of the mediators of early atherosclerosis in obstructive sleep apnea syndrome?
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015
JAG1 gene polymorphism is related to systemic blood pressure in patients with obstructive sleep apnoea
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016
Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept